Mao J, Price D D, Hayes R L, Lu J, Mayer D J
Department of Anesthesiology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
Brain Res. 1992 Dec 11;598(1-2):271-8. doi: 10.1016/0006-8993(92)90193-d.
Central activation of excitatory amino acid receptors has been implicated in neuropathic pain following nerve injury. In a rat model of painful peripheral mononeuropathy, we compared the effects of non-competitive NMDA receptor antagonists (MK 801 and HA966) and a non-NMDA receptor antagonist (CNQX) on induction and maintenance of thermal hyperalgesia induced by chronic constrictive injury (CCI) of the rat common sciatic nerve. Thermal hyperalgesia to radiant heat was assessed by using a foot-withdrawal test and NMDA/non-NMDA receptor antagonists were administered intrathecally onto the lumbar spinal cord before and after nerve injury. Four daily single treatments with 20 nmol HA966 or CNQX beginning 15 min prior to nerve ligation (pre-injury treatment), reliably reduced thermal hyperalgesia in CCI rats on days 3, 5, 7 and 10 after nerve ligation. Thermal hyperalgesia was also reduced in CCI rats receiving a single post-injury treatment with HA966 (20 or 80 nmol) or MK 801 (5 or 20 nmol) on day 3 after nerve ligation when thermal hyperalgesia was well developed. In contrast, a single post-injury CNQX (20 or 80 nmol) treatment failed to reduce thermal hyperalgesia or to potentiate effects of HA966 or MK 801 (5 or 20 nmol) on thermal hyperalgesia in CCI rats. Moreover, multiple post-injury CNQX treatments utilizing the same dose regime as employed for the pre-injury treatment attenuated thermal hyperalgesia but only when the treatment began 1 or 24 h (but not 72 h) after nerve ligation.(ABSTRACT TRUNCATED AT 250 WORDS)
兴奋性氨基酸受体的中枢激活与神经损伤后的神经性疼痛有关。在疼痛性外周单神经病变的大鼠模型中,我们比较了非竞争性NMDA受体拮抗剂(MK 801和HA966)和非NMDA受体拮抗剂(CNQX)对大鼠坐骨神经慢性压迫性损伤(CCI)诱导和维持热痛觉过敏的影响。通过足部撤离试验评估对辐射热的热痛觉过敏,并在神经损伤前后将NMDA/非NMDA受体拮抗剂鞘内注射到腰脊髓。在神经结扎前15分钟开始,每天单次给予20 nmol HA966或CNQX,连续4天(损伤前治疗),可可靠地降低CCI大鼠在神经损伤后第3、5、7和10天的热痛觉过敏。在神经结扎后第3天热痛觉过敏充分发展时,接受单次损伤后HA966(20或80 nmol)或MK 801(5或20 nmol)治疗的CCI大鼠的热痛觉过敏也有所降低。相比之下,单次损伤后CNQX(20或80 nmol)治疗未能降低CCI大鼠的热痛觉过敏,也未能增强HA966或MK 801(5或20 nmol)对热痛觉过敏的作用。此外,采用与损伤前治疗相同剂量方案的多次损伤后CNQX治疗可减轻热痛觉过敏,但仅在神经结扎后1或24小时(而非72小时)开始治疗时有效。(摘要截断于250字)